Last reviewed · How we verify
NCT03230435: QOLAN-DK
Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.
trial testing Treatment settings as usual. in Anorexia Nervosa in 496 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | René Klinkby Støving |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 496 |
| Start date | 1 March 2017 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Treatment settings as usual.
Conditions studied
- Anorexia Nervosa — all drugs for Anorexia Nervosa →
- Health-Related Quality Of Life — all drugs for Health-Related Quality Of Life →
Sponsor
René Klinkby Støving
Who can join
Adults 13 to 40, any sex, with Anorexia Nervosa or Health-Related Quality Of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eating disorders (ED) comprise a multitude of symptoms involving a disturbed body image and a preoccupation with food or bodyweight. EDs are often difficult to treat, in part due to the lack of motivation for improvement. Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disease, and less than half of patients will recover from the disease. Studies have found that patients suffering from AN have impaired health-related quality of life (HRQoL) compared to the general population. It has also been suggested that despite improvement in clinical parameters, patients report deterioration in HRQoL, which is in line with a study finding low agreement between patient perceived outcome and clinician assessed characteristics. To evaluate the patients' perception of their disease, it is important to develop reliable and valid assessment tools. Previously generic questionnaires have been used to assess HRQoL in Danish ED patients, as no disease-specific questionnaires have been developed. Translating and validating a disease-specific questionnaire would provide a useful tool in assessing current treatment and in developing new treatment options. This study aimed to develop a Danish version of an internationally disease-specific HRQoL questionnaire. Furthermore, HRQoL is assessed in patients who have gone through shorter or longer treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Explanatory Factors for Disease-Specific Health-Related Quality of Life in Women with Anorexia Nervosa.
Winkler LA, Gudex C, Lichtenstein MB, Røder ME, et al · · 2021 · cited 6× · PMID 33918786 · DOI 10.3390/jcm10081592
Verify or expand the search:
- PubMed search for NCT03230435
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anorexia Nervosa
Currently open trials in the same condition.
- NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
- NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders · NA · recruiting
- NCT07188155 — Adapting Exposure for Adolescent AN · NA · recruiting
- NCT07143981 — The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa · recruiting
- NCT07311356 — Prognosis of Early-onset Anorexia Nervosa · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03230435 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by René Klinkby Støving
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03230435.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing